首页 > 最新文献

Evidence-based Oncology最新文献

英文 中文
Foscarnet is as effective as ganciclovir for preventing cytomegalovirus disease in people with cytomegalovirus infection after allogeneic stem cell transplantation 在同种异体干细胞移植后巨细胞病毒感染患者中,Foscarnet与更昔洛韦同样有效地预防巨细胞病毒病
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0038
Nina Singh MD
{"title":"Foscarnet is as effective as ganciclovir for preventing cytomegalovirus disease in people with cytomegalovirus infection after allogeneic stem cell transplantation","authors":"Nina Singh MD","doi":"10.1054/ebon.2002.0038","DOIUrl":"https://doi.org/10.1054/ebon.2002.0038","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 128-130"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71804438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination chemo-immunotherapy does not improve survival compared with chemotherapy alone for advanced malignant melanoma 与单独化疗相比,化疗免疫联合治疗不能提高晚期恶性黑色素瘤的生存率
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0033
Robert O. Dillman MD (Medical Director)
{"title":"Combination chemo-immunotherapy does not improve survival compared with chemotherapy alone for advanced malignant melanoma","authors":"Robert O. Dillman MD (Medical Director)","doi":"10.1054/ebon.2002.0033","DOIUrl":"https://doi.org/10.1054/ebon.2002.0033","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 135-136"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71804440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silver-coated central venous catheters reduce catheter-related infection compared with uncoated catheters, but do not affect the risk of thrombosis for people with cancer 与未包覆的中心静脉导管相比,镀银中心静脉导管可减少导管相关感染,但不影响癌症患者血栓形成的风险
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0023
M. Wojtukiewicz, E. Sierko
{"title":"Silver-coated central venous catheters reduce catheter-related infection compared with uncoated catheters, but do not affect the risk of thrombosis for people with cancer","authors":"M. Wojtukiewicz, E. Sierko","doi":"10.1054/EBON.2002.0023","DOIUrl":"https://doi.org/10.1054/EBON.2002.0023","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"87 1","pages":"137-138"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73431576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foscarnet is as effective as ganciclovir for preventing cytomegalovirus disease in people with cytomegalovirus infection after allogeneic stem cell transplantation 在同种异体干细胞移植后巨细胞病毒感染患者中,Foscarnet与更昔洛韦同样有效地预防巨细胞病毒病
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0038
Nina Singh
{"title":"Foscarnet is as effective as ganciclovir for preventing cytomegalovirus disease in people with cytomegalovirus infection after allogeneic stem cell transplantation","authors":"Nina Singh","doi":"10.1054/EBON.2002.0038","DOIUrl":"https://doi.org/10.1054/EBON.2002.0038","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"15 1","pages":"128-130"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77146739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anthracycline-containing chemotherapy improves survival for over 60 year olds with aggressive non-Hodgkin lymphoma 含蒽环类药物化疗可提高60岁以上侵袭性非霍奇金淋巴瘤患者的生存率
Pub Date : 2002-09-01 DOI: 10.1054/ebon.2002.0024
Julie M. Vose MD
{"title":"Anthracycline-containing chemotherapy improves survival for over 60 year olds with aggressive non-Hodgkin lymphoma","authors":"Julie M. Vose MD","doi":"10.1054/ebon.2002.0024","DOIUrl":"https://doi.org/10.1054/ebon.2002.0024","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 3","pages":"Pages 126-127"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71804467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anthracycline-containing chemotherapy improves survival for over 60 year olds with aggressive non-Hodgkin lymphoma 含蒽环类药物化疗可提高60岁以上侵袭性非霍奇金淋巴瘤患者的生存率
Pub Date : 2002-09-01 DOI: 10.1054/EBON.2002.0024
J. Vose
{"title":"Anthracycline-containing chemotherapy improves survival for over 60 year olds with aggressive non-Hodgkin lymphoma","authors":"J. Vose","doi":"10.1054/EBON.2002.0024","DOIUrl":"https://doi.org/10.1054/EBON.2002.0024","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"32 1","pages":"126-127"},"PeriodicalIF":0.0,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91540050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adding interferon alfa to induction chemotherapy improves disease-free survival in non-Hodgkin's lymphoma 在诱导化疗中加入干扰素可提高非霍奇金淋巴瘤的无病生存率
Pub Date : 2002-06-01 DOI: 10.1054/ebon.2002.0018
Stefano Sacchi (Prof.)
{"title":"Adding interferon alfa to induction chemotherapy improves disease-free survival in non-Hodgkin's lymphoma","authors":"Stefano Sacchi (Prof.)","doi":"10.1054/ebon.2002.0018","DOIUrl":"https://doi.org/10.1054/ebon.2002.0018","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 2","pages":"Pages 71-73"},"PeriodicalIF":0.0,"publicationDate":"2002-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71827050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antigenemia testing is superior to bronchoscopy for cytomegalovirus screening following bone marrow transplant 在骨髓移植后进行巨细胞病毒筛查时,抗原检测优于支气管镜检查
Pub Date : 2002-06-01 DOI: 10.1054/ebon.2002.0010
John A. Zaia MD
{"title":"Antigenemia testing is superior to bronchoscopy for cytomegalovirus screening following bone marrow transplant","authors":"John A. Zaia MD","doi":"10.1054/ebon.2002.0010","DOIUrl":"https://doi.org/10.1054/ebon.2002.0010","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 2","pages":"Pages 60-62"},"PeriodicalIF":0.0,"publicationDate":"2002-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71827648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiotherapy increases intestinal adverse effects and decreases social functioning compared with deferred therapy in people with localised prostate cancer 与延期治疗相比,放疗增加了局部前列腺癌患者的肠道不良反应并降低了社会功能
Pub Date : 2002-06-01 DOI: 10.1054/EBON.2002.0007
N. Turner
{"title":"Radiotherapy increases intestinal adverse effects and decreases social functioning compared with deferred therapy in people with localised prostate cancer","authors":"N. Turner","doi":"10.1054/EBON.2002.0007","DOIUrl":"https://doi.org/10.1054/EBON.2002.0007","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"31 1","pages":"96-98"},"PeriodicalIF":0.0,"publicationDate":"2002-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79092749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intermediate dose cytarabine plus mitoxantrone is as effective as, but more toxic than, low-dose cytarabine for postremission therapy among older patients with primary acute myeloid leukemia 中剂量阿糖胞苷加米托蒽醌对老年原发性急性髓性白血病缓解后治疗与低剂量阿糖胞苷一样有效,但毒性更大
Pub Date : 2002-06-01 DOI: 10.1054/ebon.2002.0019
Matt Kalaycio MD
{"title":"Intermediate dose cytarabine plus mitoxantrone is as effective as, but more toxic than, low-dose cytarabine for postremission therapy among older patients with primary acute myeloid leukemia","authors":"Matt Kalaycio MD","doi":"10.1054/ebon.2002.0019","DOIUrl":"https://doi.org/10.1054/ebon.2002.0019","url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"3 2","pages":"Pages 74-76"},"PeriodicalIF":0.0,"publicationDate":"2002-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1054/ebon.2002.0019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71802843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Evidence-based Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1